Merck & Co Inc logo

Merck & Co Inc

$ 103.28 (-0.38%) Feb 3
P/E:
18.03
P/B:
5.87
Market Cap:
$ 260.99B
Enterprise V:
$ 280.16B
Volume:
14.94K
Avg Vol (2M):
62.05K
Also Trade In:
Volume:
14.94K
Market Cap $:
260.99B
PE Ratio:
18.03
Avg Vol (2-Month):
62.05K
Enterprise Value $:
280.16B
PB Ratio:
5.87

Business Description

Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.